Literature for cilastatin (M19.001 inhibitor)

(Topics flags: S Structure, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2015
1. Moulton,R.D., Ruterbories,K.J., Bedwell,D.W. and Mohutsky,M.A.
   In vitro characterization of the bioconversion of pomaglumetad methionil, a novel metabotropic glutamate 2/3 receptor agonist peptide prodrug
   Drug Metab Dispos43, 756-761. PubMed  Europe PubMed DOI  I
2002
2. [YEAR:9-8-2002]Nitanai,Y., Satow,Y., Adachi,H. and Tsujimoto,M.
   Crystal structure of human renal dipeptidase involved in beta-lactam hydrolysis
   J Mol Biol321, 177-184. PubMed  Europe PubMed DOI  S  I
1995
3. Keynan,S., Hooper,N.M., Felici,A., Amicosante,G. and Turner,A.J.
   The renal membrane dipeptidase (dehydropeptidase I) inhibitor, cilastatin, inhibits the bacterial metallo-beta-lactamase enzyme CphA
   Antimicrobial Agents Chemother39, 1629-1631. PubMed  Europe PubMed  I
1984
4. [YEAR:10-12-1984]Campbell,B.J., Forrester,L.J., Zahler,W.L. and Burks,M.
   Beta-lactamase activity of purified and partially characterized human renal dipeptidase
   J Biol Chem259, 14586-14590. PubMed  Europe PubMed  I
1983
5. Kahan,F.M., Kropp,H., Sundelof,J.G. and Birnbaum,J.
   Thienamycin: development of imipenen-cilastatin
   J Antimicrob Chemother12 Suppl D, 1-35. PubMed  Europe PubMed  I